Risk Mitigation Design for the Drug Supply Chain at the Pharmacy Installation of Hospital X in Surakarta Using the SCOR and House of Risk Methods
DOI:
https://doi.org/10.55927/fjst.v5i4.46Keywords:
Risk Mitigation, SCOR, House of Risk, Drug Supply Chain, Pharmacy InstallationAbstract
Hospitals must maintain medicine availability in the right type, quantity, quality, and time. This study mapped drug supply chain risks at the Pharmacy Installation of Hospital X, Surakarta, and prioritized mitigation using SCOR and House of Risk. A descriptive design was applied to four pharmacists directly involved in planning, procurement, compounding, distribution, and return processes. The study identified 21 risk events and 21 risk agents. The main risk agents were emergency time pressure, insufficient pharmacy staff, slow bureaucracy, recurring e-catalog problems, limited SIMRS support for e-prescribing, and weak distributor communication. The priority actions were routine cross-unit coordination, escalation of service barriers to leadership, and service quality standards for monitoring
References
Cahyani, Z. D., Pribadi, S. R. W., & Baihaqi, I. (2016). Studi implementasi model House of Risk (HOR) untuk mitigasi risiko keterlambatan material dan komponen impor pada pembangunan kapal baru. Jurnal Teknik ITS, 5(2).
Campling, N., Breen, L., Miller, E., Birtwistle, J., Richardson, A., Bennett, M., & Latter, S. (2022). Issues affecting supply of palliative medicines into community pharmacy: A qualitative study of community pharmacist and pharmaceutical wholesaler/distributor perspectives. Exploratory Research in Clinical and Social Pharmacy, 6, 100132.
George, S., & Elrashid, S. (2023). Inventory management and pharmaceutical supply chain performance of hospital pharmacies in Bahrain: A structural equation modeling approach. SAGE Open, 13(1), 1-13.
Govindan, K., Mina, H., & Alavi, B. (2020). A decision support system for demand management in healthcare supply chains considering epidemic outbreaks: A case study of coronavirus disease 2019 (COVID-19). Transportation Research Part E: Logistics and Transportation Review, 138, 101967.
Hadi, J. A., Febrianti, M. A., Yudhistira, G. A., & Qurtubi, Q. (2020). Identifikasi risiko rantai pasok dengan metode House of Risk (HOR). Performa: Media Ilmiah Teknik Industri, 19(2), 85-94.
Kusreni, K., Jati, S. P., & Suhartono, S. (2023). Analisis manajemen risiko pada supply chain persediaan farmasi saat pandemi Covid-19. Cendekia Journal of Pharmacy, 7(1), 29-36.
Mehralian, G., Zarenezhad, F., & Ghatari, A. (2015). Developing a model for an agile supply chain in pharmaceutical industry. The Electronic Library, 34(1), 1-5.
Mensah, J., Annan, J., & Asamoah, D. (2015). Optimizing drug supply chain in hospital pharmacy department: Empirical evidence from a developing country. Business and Economic Research, 5(2), 153.
Permenkes RI. (2016). Standar pelayanan kefarmasian di rumah sakit. Kementerian Kesehatan Republik Indonesia.
Samodro, G. (2020). Pendekatan House of Risk untuk penilaian risiko alur penyediaan dan pendistribusian obat (studi kasus pada Apotek ABC). Opsi, 13(2), 92.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Viktorda S. Noti, Jason Merari Peranginangin, Iswandi

This work is licensed under a Creative Commons Attribution 4.0 International License.






























